论文部分内容阅读
目的:探讨罗哌卡因复合舒芬太尼连续硬膜外持续镇痛用于分娩镇痛的疗效、时机选择及对母婴的影响。方法:以2007年7月～2008年10月自愿实行分娩镇痛的257例初产妇为观察组,以同期分娩的257例初产妇为对照组,观察两组的产程时间、镇痛效果、分娩方式、产后出血及新生儿情况。结果:两组比较,观察组较对照组的镇痛效果明显,第一产程明显缩短,剖宫产率明显降低;阴道助产率、产后出血及新生儿Apgar评分两组差异无统计学意义。结论:罗哌卡因复合舒芬太尼用于分娩镇痛可加速产程,降低剖宫产率,减轻分娩疼痛,对母婴无不良影响,是一种安全有效的无痛分娩方法。
Objective: To investigate the curative effect, timing and effect of continuous intravenous epidural analgesia with ropivacaine and sufentanil on labor analgesia. Methods: From July 2007 to October 2008, 257 cases of primipara caused by labor analgesia were randomly selected as the observation group. 257 cases of primiparous women were selected as the control group. The duration of labor, analgesic effect, delivery Way, postpartum hemorrhage and neonatal conditions. Results: Compared with the control group, the analgesic effect was obvious in the two groups. The first stage of labor was significantly shortened and the rate of cesarean section was significantly decreased. There was no significant difference between the two groups in terms of vaginal delivery rate, postpartum hemorrhage and neonatal Apgar score. Conclusion: The combination of ropivacaine and sufentanil for labor analgesia can accelerate the labor process, reduce the cesarean section rate, relieve the pain of childbirth and have no adverse effect on the mother and child. It is a safe and effective painless delivery method.